Janet Hall - Guardion Health President CEO

GHSI Stock  USD 8.10  0.00  0.00%   

CEO

Janet Hall is President CEO of Guardion Health Sciences
Age 65
Address 2925 Richmond Avenue, Houston, TX, United States, 77098
Phone800 873 5141
Webhttps://www.guardionhealth.com

Guardion Health Management Efficiency

The company has return on total asset (ROA) of (0.1466) % which means that it has lost $0.1466 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0148 %, meaning that it created $0.0148 on every $100 dollars invested by stockholders. Guardion Health's management efficiency ratios could be used to measure how well Guardion Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Guardion Health's Return On Tangible Assets are increasing as compared to previous years. The Guardion Health's current Return On Assets is estimated to increase to 0.01, while Return On Capital Employed is forecasted to increase to (0.35). As of now, Guardion Health's Return On Assets are increasing as compared to previous years. The Guardion Health's current Asset Turnover is estimated to increase to 1.08, while Total Assets are projected to decrease to under 10.1 M.
The company currently holds 3.81 K in liabilities. Guardion Health Sciences has a current ratio of 11.05, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Guardion Health until it has trouble settling it off, either with new capital or with free cash flow. So, Guardion Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Guardion Health Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Guardion to invest in growth at high rates of return. When we think about Guardion Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

CEO Age

Peter BalaRegencell Bioscience Holdings
N/A
Amy MilesRegencell Bioscience Holdings
49
Rupert HaynesFSD Pharma Class
N/A
Dr BPHARMFSD Pharma Class
53
Hermann LuebbertBiofrontera
68
Ilan MBAPainreformLtd
55
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California. Guardion Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. Guardion Health Sciences (GHSI) is traded on NASDAQ Exchange in USA. It is located in 2925 Richmond Avenue, Houston, TX, United States, 77098 and employs 9 people. Guardion Health is listed under Personal Care Products category by Fama And French industry classification.

Management Performance

Guardion Health Sciences Leadership Team

Elected by the shareholders, the Guardion Health's board of directors comprises two types of representatives: Guardion Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guardion. The board's role is to monitor Guardion Health's management team and ensure that shareholders' interests are well served. Guardion Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guardion Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Weingarten, Independent Secretary
Janet Hall, President CEO
Jeffrey Benjamin, Chief Officer
Craig Sheehan, Chief Officer
Bret Scholtes, CEO Pres
Katie Cox, Chief Officer

Guardion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guardion Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guardion Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guardion Health's short interest history, or implied volatility extrapolated from Guardion Health options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Guardion Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardion Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardion Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardion Health Sciences Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardion Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Guardion Stock analysis

When running Guardion Health's price analysis, check to measure Guardion Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardion Health is operating at the current time. Most of Guardion Health's value examination focuses on studying past and present price action to predict the probability of Guardion Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardion Health's price. Additionally, you may evaluate how the addition of Guardion Health to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Guardion Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardion Health. If investors know Guardion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardion Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.12
Revenue Per Share
9.638
Quarterly Revenue Growth
0.077
Return On Assets
(0.15)
Return On Equity
0.0148
The market value of Guardion Health Sciences is measured differently than its book value, which is the value of Guardion that is recorded on the company's balance sheet. Investors also form their own opinion of Guardion Health's value that differs from its market value or its book value, called intrinsic value, which is Guardion Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardion Health's market value can be influenced by many factors that don't directly affect Guardion Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardion Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardion Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardion Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.